Search
for
Sort by
Research 181–210 of 748
- The JAK/STAT signaling pathway: from bench to clinic
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
- Quiescent Tissue Stem Cells Evade Immune Surveillance
- Cutting Edge: Memory Regulatory T Cells Require IL-7 and Not IL-2 for Their Maintenance in Peripheral Tissues
- Recurrent implantation failure: A comprehensive summary from etiology to treatment
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- The Skin Microbiome: Current Landscape and Future Opportunities
- Immunomodulatory properties of mesenchymal stromal/stem cells: The link with metabolism
- FOXN1: A Master Regulator Gene of Thymic Epithelial Development Program
- Targeting integrin pathways: mechanisms and advances in therapy
- Immune-Epithelial Cross Talk in Regeneration and Repair
- Cutaneous Neuroimmune Interactions in Peripheral Neuropathic Pain States
- Unraveling the web of defense: the crucial role of polysaccharides in immunity
- SYK inhibitor entospletinib prevents ocular and skin GVHD in mice
- Toll-like receptor-targeted anti-tumor therapies: Advances and challenges
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- The Effects of Androgens on T Cells: Clues to Female Predominance in Autoimmune Liver Diseases?
- Autoimmune polyendocrine syndrome type 1: an Italian survey on 158 patients
- The role of WNT10B in physiology and disease: A 10-year update
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Innate type 2 immunity controls hair follicle commensalism by Demodex mites
- PPAR‐γ signalling as a key mediator of human hair follicle physiology and pathology
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- Regenerative Medicine-Based Treatment for Vitiligo: An Overview
- Identification of an Intronic Regulatory Element Necessary for Tissue-Specific Expression of <i>Foxn1</i> in Thymic Epithelial Cells
- Nanomedicine-based immunotherapy for tissue regeneration
- Lifestyle Factors Involved in the Pathogenesis of Alopecia Areata
- Recent advances in the role of neuroregulation in skin wound healing